Jointly sponsored by ACCP and the American Society of Health-System Pharmacists

Program Overview Course Content Faculty Preview Sample CE Credit Fees Goals & Target Audience Learning Objectives Faculty Disclosures Table of Contents (coming soon) Board Certification FAQs Financial Support

ACCP will no longer take orders for the 2010 Oncology Pharmacy Preparatory Review Course beginning April 1.

The 2011 Oncology Pharmacy Preparatory Review Course will be available for pre-order beginning in April.

This course is designed to help oncology pharmacy practitioners prepare for the Board of Pharmacy Specialties (BPS) Oncology Pharmacy Specialty Certification examination, and obtain a broad and detailed update to their knowledge in oncology. Jointly sponsored by ACCP and the American Society of Health-System Pharmacists, the course content is based on the domains and knowledge areas tested on the examination.

The detailed workbook, filled with patient cases and practice-based self-assessment questions, is an excellent resource for assessing knowledge in multiple areas of oncology practice. The instructional materials, developed by clinical and educational experts and derived from the live presentation of the 2010 course.

The Oncology Pharmacy Preparatory Review Course covers the following content:

	Linda S. Tyler, Pharm.D., FASHP Director of Pharmacy Hospital and Clinics University of Utah Salt Lake City, Utah
	Chad Barnett, Pharm.D., BCOP Breast Cancer Specialist The University of Texas MD Anderson Cancer Center Houston, Texas
	Ashley Morris, Pharm.D., BCOP Clinical Associate Division of Cellular therapy Duke University Medical Center Durham, North Carolina
	Theresa Mays, Pharm.D., BCOP Director, Investigational Drug Department Accelerated Research Therapeutics San Antonio, Texas
	Jill M. Kolesar, Pharm.D., FCCP, BCPS Associate Professor School of Pharmacy Madison, Wisconsin
	Patrick J. Medina, Pharm.D., BCOP Associate Professor University of Oklahoma, College of Pharmacy Oklahoma City, Oklahoma
	Val Adams, Pharm.D., BCOP Associate Professor of Pharmacy Practice and Science University of Kentucky College of Pharmacy Lexington, Kentucky
	Dina Patel, Pharm.D., BCOP Specialist-GI Medical Oncology The University of Texas MD Cancer Center Houston, Texas
	John Valgus, Pharm.D., BCOP Hematology/Oncology Senior Clinical Specialist University of North Carolina Hospitals and Clinics Chapel Hill, North Carolina
	R. Donald Harvey, Pharm.D., BCPS, BCOP Assistant Professor of hematology and Oncology Director, Phase I Unit Winship Cancer Center Emory University School of Medicine Atlanta, Georgia
	Christopher A. Fausel, Pharm.D., BCPS, BCOP Clinical Specialist Indiana University Hospital Indianapolis, Indiana
	Dayna L. McCauley, Pharm.D., BCOP Clinical Specialist Stony Brook University Hospital Stony Brook, New York
	Mark T. Holdsworth, Pharm.D., BCOP Associate Professor, Pharmacy and Pediatrics Area Head College of Pharmacy University of New Mexico Albuquerque, New Mexico

• Breast Cancer

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education. The Activity is approved for 25.5 contact hours; Activity Numbers:

• Symptom and Pain Management
  Symptom Management; Disease Related Symptoms: Hypercalcemia, SVC, Malignant Effusions; Pain Management & Bone Metastes, Spinal Cord Compression; Pharmacology-A review of the major classes of chemotherapy
  Activity No. 0217-9999-10-066-H01-P
• Blood Cancers and Bone Marrow
  Bone Marrow Transplantation; Acute Leukemia/Tumor Lysis Syndrome; Chronic Leukemias; Lymphomas/Multiple Myeloma
  Activity No. 0217-9999-10-067-H01-P
• Other Cancers
  GI Cancers, Escophageal, Liver, Stomach; Melanoma and Skin Cancer, Sarcomas, Lung; Head and Neck and Brain Cancer; Pediatric Malignancies; Colon
  Activity No. 0217-9999-10-068-H01-P
• Women and Men's Cancers and Genitourinary
  Breast; Ovarian and Gynecologic Malignancies; Genitourinary Cancers, Renal, Testicular, Bladder; Prostate
  Activity No. 0217-9999-10-069-H01-P
• Developments, Guidelines and Research
  Drug Information and Guidelines; The Anticancer Drug Development Process; Oncology Drug Literature, Biostatistics and Study Design
  Activity No. 0217-9999-10-070-H04-P

To receive continuing education credit, the Web-based post test must be successfully completed and submitted to ACCP by October 31, 2011. To receive BCOP recertification credit, the Web-based post test must be successfully completed and submitted to ACCP by November 30, 2010.

Statements of ACPE credit will be available at www.accp.com/ce to participants immediately after submission of a passing score for each Web-based post test.

Statements of BCOP recertification credit will be available at www.accp.com/ce to participants immediately after submission of a combined passing score for all five Web-based post tests.

NOTE: ASHP and HOPA members must call (913) 492-3311 to receive member pricing.

Shipping and Handling Information

To access the online materials and post tests you will need to sign into ACCP's CE Center at www.accp.com/ce. Please allow up to two business days for your order to be processed and your item to appear in the CE Center.

This course is partially supported by an educational grant from: